Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Leila Chebane"'
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1187 (2021)
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have unprecedentedly improved global prognosis in several types of cancers. However, they are associated with the occurrence of immune-related adverse events. Despite their l
Externí odkaz:
https://doaj.org/article/e09daae110144876b4a0484be876e850
Autor:
Florentia Kaguelidou, Vanessa Rousseau, Leila Chebane, Jean-Louis Montastruc, Marie Boyer Gervoise, Geneviève Durrieu, Alexandra Weckel, Joëlle Michot, Véronique Pizzoglio-Bellaudaz, Adrien Gainville
Publikováno v:
Pediatric Drugs. 23:87-93
Hearing loss can have a negative impact on communication, with significant vocational, educational, and social consequences. Drugs are one of the causes of hearing loss in children. The objective of our study was to describe drug-induced hearing loss
Autor:
Vanessa Rousseau, Jean-Louis Montastruc, Leila Chebane, Claire de Canecaude, Margaux Lafaurie, Geneviève Durrieu
Publikováno v:
British Journal of Clinical Pharmacology. 87:683-686
Several papers have described hyponatraemia with tramadol. However, in most reports, several confounding factors can be found. We used the WHO pharmacovigilance database (VigiBase®) to investigate if tramadol alone could be associated with hyponatra
Autor:
Vanessa Rousseau, Haleh Bagheri, Leila Chebane, Yoann Zelmat, Agnès Sommet, Jean-Louis Montastruc
Publikováno v:
Drug Safety. 43:561-566
Fluoroquinolones are widely used to treat bacterial infections. Many in vitro and in vivo studies have established a chemical relationship between fluoroquinolones’ particular chemical structure and photosensitivity. The aim of this study was to es
Publikováno v:
Diagnostics, Vol 11, Iss 1187, p 1187 (2021)
Diagnostics
Diagnostics
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have unprecedentedly improved global prognosis in several types of cancers. However, they are associated with the occurrence of immune-related adverse events. Despite their l
Autor:
Maryse Lapeyre-Mestre, Jean-Louis Montastruc, François Montastruc, Tatiana Pacheco‐Paez, Leila Chebane, Christel Renoux, Vanessa Rousseau
Publikováno v:
Movement Disorders. 35:176-180
Background Use of gabapentinoids is increasing. Following recent case reports, we investigated a putative risk of parkinsonism with pregabalin or gabapentin. Methods A disproportionality analysis of 5,653,547 individual case safety reports in the Wor
Autor:
Leila Chebane, Jacques Amar, Béatrice Bouhanick, Vanessa Rousseau, François Montastruc, Jean-Louis Montastruc, Pierre Sabatier
Publikováno v:
European Journal of Clinical Pharmacology. 75:1593-1598
Recent studies have discussed the risk of breast cancer with antihypertensive drugs. For spironolactone, data are conflicting. The present paper investigates this potential signal in VigiBase®, the World Health Organization Global Individual Case Sa
Autor:
Vanessa Rousseau, Leila Chebane, Alexis Revet, Davy Touafchia, Maryse Lapeyre-Mestre, François Montastruc
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 35
Objectives: While drug-induced tics have been described, in particular with neuroleptics, psychostimulants, or anti-epileptics, the strength and the direction of these associations are still debated. The aim of this study was to investigate the assoc
Autor:
François Montastruc, Alexis Revet, Simon Barthez, Annie-Pierre Jonville-Béra, Leila Chebane, Maryse Lapeyre-Mestre, Véronique Pizzoglio, Laurent Chouchana, Jean-Philippe Raynaud
Publikováno v:
European journal of clinical pharmacology
European journal of clinical pharmacology, 2020, ⟨10.1007/s00228-020-02944-7⟩
European journal of clinical pharmacology, 2020, ⟨10.1007/s00228-020-02944-7⟩
International audience; PURPOSE: Despite their frequent use in children and adolescents, the evidence for efficacy and safety of antidepressants (ATDs) in this population is scarce and off-label prescribing common. The aim of this study was to descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f541d514b509c780098995b584280b86
https://hal.archives-ouvertes.fr/hal-03159449
https://hal.archives-ouvertes.fr/hal-03159449
Autor:
François Montastruc, Vanessa Rousseau, Leila Chebane, Christine Damase-Michel, Haleh Bagheri, Geneviève Durrieu, Maryse Lapeyre-Mestre, Isabelle Lacroix, Jean-Louis Montastruc, Emilie Jouanjus
Publikováno v:
Drug Safety. 41:511-514
The use of mobile apps is increasing in medicine. In pharmacovigilance, mobile apps may help to increase adverse drug reaction reporting and improve the communication of safety issues. The Toulouse University Pharmacovigilance Center has developed Vi